Himalaya Nutravedics India Ltd
Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged
in the manufacturing, marketing, and
distribution of Ayurvedic and nutraceutical formulations.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of BSE SME IPO
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
-
Reply To The Clarification Sought With Regard To The Price Movement
- Company clarified recent share price movement is market-driven; no undisclosed material event exists.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Submitted Regulation 74(5) depository certificate for quarter ended 30 September 2026.
-
Clarification sought from Himalaya Nutravedics India Ltd
- Exchange has sought clarification from Himalaya Nutravedics India Ltd on October 16, 2026 with reference to significant movement in price, in order to ensure that …
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Commercial Suit Filed Against The Company
- Trademark suit filed Oct 2-3, 2026 seeks injunctions, name change and ₹2.00 crore damages.
- Announcement under Regulation 30 (LODR)-Investor Presentation
Concalls
-
Oct 2026PPT
Business Overview[1]
Himalaya Nutravedics India manufactures, markets, and distributes Ayurvedic and Nutraceutical formulations in India. The
company also undertakes third-party
contract manufacturing for other Ayurvedic
and nutraceutical companies. Its portfolio
spans classical Ayurvedic formulations, proprietary Ayurvedic formulations and nutraceutical supplements across multiple dosage forms.